Alfa-2a is used as a fixed weekly dose. Alfa-2b is used as a weekly dose based on the weight of the patient. There are other differences between the two drugs, but they are mostly technical and are used by the prescribing physician. For example, alfa-2a has a relatively constant absorption after injection and is distributed mostly in the blood and organs. But alfa-2b has a rapid absorption and a wider distribution in the body.
Until January 2008, no data directly compared these two medicines. That has changed with a large clinical study known as IDEAL. This should provide interesting results that will allow physicians additional insight into these powerful chronic hepatitis C therapies.
Source:
Berenguer M, Wright TL. Hepatitis C. In: M Feldman, LS Friedman, LJ Brandt (eds), Gastrointestinal and Liver Disease, 8e. Philadelphia, Elsevier, 2006. 1701.

